DARBESIS 60 mg Injection contains Darbepoetin Alfa 60 mcg. It is an erythropoiesis-stimulating agent (ESA) that helps the body produce more red blood cells by stimulating bone marrow activity.
Uses:
-
Treatment of anemia associated with chronic kidney disease (CKD)
-
Treatment of anemia caused by chemotherapy in certain cancer patients
-
Helps reduce the need for blood transfusions in eligible patients
-
Supports increased red blood cell production
Dose:
-
Adults: Dose is individualized based on hemoglobin level, medical condition, and response to treatment
-
Administered by subcutaneous injection or intravenous injection as directed by a physician
-
Dosing schedule may be weekly, every 2 weeks, or monthly depending on the condition
-
Regular monitoring of hemoglobin levels is required
-
Follow the prescribed dose and duration as advised by a healthcare professional